Literature DB >> 29124440

Orbital myositis as a manifestation of primary antiphospholipid syndrome.

Seunghee Na1, Taewon Kim2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29124440     DOI: 10.1007/s10072-017-3189-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

1.  Scleritis as the presenting sign of primary antiphospholipid syndrome.

Authors:  O M Durrani; D A Cameron-Swaby; S Bowman; J R Ainsworth
Journal:  Eye (Lond)       Date:  2001-08       Impact factor: 3.775

2.  Role of divalency in the high-affinity binding of anticardiolipin antibody-beta 2-glycoprotein I complexes to lipid membranes.

Authors:  G M Willems; M P Janssen; M M Pelsers; P Comfurius; M Galli; R F Zwaal; E M Bevers
Journal:  Biochemistry       Date:  1996-10-29       Impact factor: 3.162

3.  Ocular features associated with anticardiolipin antibodies: a descriptive study.

Authors:  E Miserocchi; S Baltatzis; C S Foster
Journal:  Am J Ophthalmol       Date:  2001-04       Impact factor: 5.258

Review 4.  Anti-prothrombin antibodies and their relation with thrombosis and lupus anticoagulant.

Authors:  P G de Groot; D A Horbach; M J Simmelink; E van Oort; R H Derksen
Journal:  Lupus       Date:  1998       Impact factor: 2.911

Review 5.  Ocular findings in systemic lupus erythematosus.

Authors:  Samir S Shoughy; Khalid F Tabbara
Journal:  Saudi J Ophthalmol       Date:  2016-02-16
  5 in total
  1 in total

Review 1.  Orbital myositis in systemic lupus erythematosus: a case-based review.

Authors:  Voulgari V Paraskevi; Venetsanopoulou I Aliki; Pieta Antigone; Tziortzioti Zoi; Zikou K Anastasia; Drosos A Alexandros
Journal:  Rheumatol Int       Date:  2022-04-19       Impact factor: 3.580

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.